Prescient Therapeutics Limited

A$0.05As of Sun 8 Nov 2026, 12:00 UTC
ASX:PTXHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (6.25%)
Div yield —
ROE (54.73%)
Biotechnology
Beta (5Y) 0.81
PE TTM —
TSR TTM 8.00%
Mkt cap A$61.77M
ROIC (34.58%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0632
17.00%
(78.93%)
Hold 11|5|6|7|8
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
16.92%
24.74%
24.66%
30.56%
Revenue$M
4.024
4.184
4.213
4.436
8.78%
9.19%
8.93%
13.67%
Peers (US$42.42M)
Cap (US$)
PE
52.58M
—
Capital
TTM
5Y
10Y
Leveragex
0.393
(0.101)
(0.084)
EBIT/Intx
2.834
0.126
0.126
Own earn%
(60.64)
15.44
11.25
Sh yield%
30.40
11.61
14.65
Owners
Insiders/Inst%
0.61
63.41
Short interest%
0.61
SBC / revenue%
5.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
13–21
$1 testx
0.0
Incr. ROIC%
66